Neurogene Inc (NGNE)
36.42
+1.60
(+4.60%)
USD |
NASDAQ |
Jun 28, 16:00
36.40
-0.02
(-0.05%)
After-Hours: 20:00
Neurogene Price to Book Value: 2.768 for June 28, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 28, 2024 | 2.768 |
| June 27, 2024 | 2.647 |
| June 26, 2024 | 2.433 |
| June 25, 2024 | 2.364 |
| June 24, 2024 | 2.413 |
| June 21, 2024 | 2.357 |
| June 20, 2024 | 2.362 |
| June 18, 2024 | 2.304 |
| June 17, 2024 | 3.040 |
| June 14, 2024 | 3.237 |
| June 13, 2024 | 3.192 |
| June 12, 2024 | 2.826 |
| June 11, 2024 | 2.826 |
| June 10, 2024 | 2.839 |
| June 07, 2024 | 2.879 |
| June 06, 2024 | 2.824 |
| June 05, 2024 | 2.848 |
| June 04, 2024 | 2.868 |
| June 03, 2024 | 2.830 |
| May 31, 2024 | 2.858 |
| May 30, 2024 | 2.586 |
| May 29, 2024 | 2.534 |
| May 28, 2024 | 2.410 |
| May 24, 2024 | 2.441 |
| May 23, 2024 | 2.394 |
| Date | Value |
|---|---|
| May 22, 2024 | 2.463 |
| May 21, 2024 | 2.472 |
| May 20, 2024 | 2.585 |
| May 17, 2024 | 2.532 |
| May 16, 2024 | 2.563 |
| May 15, 2024 | 2.553 |
| May 14, 2024 | 2.398 |
| May 13, 2024 | 2.329 |
| May 10, 2024 | 2.470 |
| May 09, 2024 | 2.524 |
| May 08, 2024 | 2.501 |
| May 07, 2024 | 2.580 |
| May 06, 2024 | 2.494 |
| May 03, 2024 | 2.760 |
| May 02, 2024 | 2.666 |
| May 01, 2024 | 2.544 |
| April 30, 2024 | 2.598 |
| April 29, 2024 | 2.516 |
| April 26, 2024 | 2.257 |
| April 25, 2024 | 2.250 |
| April 24, 2024 | 2.277 |
| April 23, 2024 | 2.348 |
| April 22, 2024 | 2.306 |
| April 19, 2024 | 2.297 |
| April 18, 2024 | 2.379 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.250
Minimum
Apr 25 2024
3.523
Maximum
Apr 01 2024
2.671
Average
2.580
Median
May 07 2024
Price to Book Value Benchmarks
| Taysha Gene Therapies Inc | 7.710 |
| CEL-SCI Corp | 4.392 |
| AIM ImmunoTech Inc | 4.620 |
| IGC Pharma Inc | 4.482 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 36.42 |
| Earnings Yield | -74.76% |
| Market Cap | 472.74M |